Le Lézard
Classified in: Science and technology
Subjects: Conference, Trade Show, Webcast

Leafly to Participate at Upcoming Investor Conferences


Leafly Holdings, Inc. ("Leafly" or "the Company") (NASDAQ: LFLY), a leading online cannabis discovery marketplace and resource for cannabis consumers, today announced that members of its management team will participate in upcoming investor conferences.

Details for the events are as follows:

Cowen 5th Annual Cannabis Conference
Thursday, December 8, 2022, at 12:30 pm ET. A live webcast and replay of the presentation may be accessed from the Events section of Leafly's Investor Relations website, https://investor.leafly.com/, if available.

The company will also be hosting meetings at the Benchmark Discovery One-on-One Investor Conference on December 1st in New York, NY.

About Leafly

Leafly helps millions of people discover cannabis each year. Our powerful tools help shoppers make informed purchasing decisions and empower cannabis businesses to attract and retain loyal customers through advertising and technology services. Learn more at Leafly.com or download the Leafly mobile app through Apple's App Store or Google Play.


These press releases may also interest you

at 07:15
Draganfly Inc. ("Draganfly" or the "Company"), an award-winning, industry-leading drone solutions and systems developer is pleased to announce a strategic collaboration with ParaZero Technologies Ltd., a pioneer in drone safety systems aimed at...

at 07:10
Science Corporation ("Science"), a leader in brain-computer interface ("BCI") technology and the developer of the Science Eye, has acquired the IP and related assets for the PRIMA retinal implant, developed by Pixium Vision SA ("Pixium") of France, a...

at 07:07
MESCIUS inc., a global provider of award-winning enterprise software development tools, is pleased to announce the Document Solutions v7.1 release. This release introduces features and enhancements to MESCIUS's server-side document APIs, JavaScript...

at 07:05
GlycoMimetics, Inc. , today announced that it will host a conference call and webcast to report first quarter 2024 financial results on Thursday, May 9, 2024 at 8:30 a.m. ET. To access the call by phone, please go to this registration link and you...

at 07:05
Harrow , a leading U.S. eyecare pharmaceutical company, today announced that it will release its financial results for the first quarter ended March 31, 2024, on Monday, May 13, 2024, after the market close. The Company will also post its first...

at 07:05
Mind Medicine (MindMed) Inc. , (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it will present detailed results from its phase 2b study...



News published on and distributed by: